Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
31.06
+0.54 (1.77%)
At close: Jul 10, 2026, 4:00 PM EDT
31.50
+0.44 (1.42%)
After-hours: Jul 10, 2026, 7:59 PM EDT
Tango Therapeutics Market Cap
Tango Therapeutics has a market cap or net worth of $4.49 billion as of July 10, 2026. Its market cap has increased by 733.97% in one year.
Market Cap
4.49B
Enterprise Value
4.15B
1-Year Change
733.97%
Ranking
Category
Stock Price
$31.06
Market Cap Chart
Since April 20, 2021, Tango Therapeutics's market cap has increased from $156.31M to $4.49B, an increase of 2,774.34%. That is a compound annual growth rate of 90.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 4.49B | 276.52% |
| Dec 31, 2025 | 1.19B | 259.49% |
| Dec 31, 2024 | 331.92M | -67.13% |
| Dec 29, 2023 | 1.01B | 57.94% |
| Dec 30, 2022 | 639.29M | -33.25% |
| Dec 31, 2021 | 957.76M | 512.74% |
| Apr 20, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CRISPR Therapeutics AG | 5.15B |
| Veradermics | 5.00B |
| Edgewise Therapeutics | 4.89B |
| Caris Life Sciences | 4.80B |
| Viking Therapeutics | 4.51B |
| ACADIA Pharmaceuticals | 4.49B |
| Relay Therapeutics | 4.36B |
| NewAmsterdam Pharma Company | 4.12B |